Tokyo, May 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061553) titled 'A Survey of Clinical Practice for Major Depressive Disorder with Anxious Distress' on May 13.
Study Type:
Observational
Primary Sponsor:
Institute - Otsuka Pharmaceutical Co., Ltd
Condition:
Condition - Major depressive disorder
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to investigate clinical practice among psychiatrists in Japan by quantifying the frequency and percentage of awareness of the DSM-5-TR specifier with anxious distress, diagnostic status and its reasons, and treatment choices for depression with anxious distress.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - -Physicians affiliated with medical institutions that provide psychiatric services.
-Psychiatrists who consented to participate in the survey.
-Psychiatrists who have treated more than 10 outpatients with depression in the month prior to providing informed consent.
Key exclusion criteria - N/A
Target Size - 600
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 03 Month 31 Day
Date of IRB - 2026 Year 04 Month 15 Day
Anticipated trial start date - 2026 Year 05 Month 15 Day
Last follow-up date - 2026 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070307
Disclaimer: Curated by HT Syndication.
